Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
The N-methyl-d-aspartate receptor antagonist, memantine, is licensed for the treatment of moderate to severe Alzheimer’s disease (AD). Memantine is administered both as a monotherapy and as an add-on therapy in patients already receiving acetylcholinesterase inhibitors. Several meta-analyses have be...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer International Publishing
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709077/ |